PreClinical

PreClinical Research For ALS

Pre Clinical Research– SPG302, SLS-005, Ketamine, Macimorelin NU-9, RNA Aptamer, CRISPR gene therapy.

Spinogenix SPG-302 :

Currently Cleared For Phase 1

Spinogenix SPG-302 :

Ketamine:

Applied for orphan drug status: FDA

Ketamine:

Macimorelin:

Preclinical research

NU-9 Preclinical research

RNA Aptamer Preclinical research

NU-9 Preclinical research

RNA Aptamer Preclinical research

Macimorelin:

Preclinical research

CRISPR gene therapy:

Preclinical research

CRISPR gene therapy: